Skip to content

AbbVie ABBV Ratios & Valuation

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
Profitability
Gross margin70.7%0.0pp70.2%+0.2pp69.7%+2.5pp70.9%+8.2pp70.7%+8.4pp
Net margin5.8%-1.5pp6.9%-0.7pp4%-5.2pp6.5%-3.3pp7.3%-3.7pp
Efficiency
Asset turnover0.5×+0.1×0.5×0.0×0.4×0.0×0.4×0.0×0.4×0.0×
Liquidity
Current ratio0.8×0.0×0.7×0.0×0.7×+0.1×0.7×-0.1×0.8×-0.2×
Per Share
Book value per share-$3.75-568%-$1.84-198%-$1.49-144%-$0.10-103%$0.80-82.3%
Valuation
Market capitalization$384.69B+3.8%$403.83B+28.6%$409.03B+17.3%$327.76B+8.2%$370.64B+14.9%
Price / earnings105.8×+17.5×95.6×+22.2×171.3×+103×87.1×+30.4×88.4×+34.6×
Price / sales6.1×-0.3×6.6×+1.0×6.9×+0.6×5.6×+0.1×6.5×+0.5×
Dividend yield3.1%+0.1pp2.9%-0.6pp2.8%-0.3pp3.5%-0.1pp3%-0.3pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are AbbVie's profit margins?
AbbVie (ABBV) runs a 70.7% gross margin and a 24.4% operating margin, with a 5.8% net margin.
Where do AbbVie's ratios come from?
Every ratio is computed from AbbVie's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.